Neurocrine Biosciences

Neurocrine Biosciences is dedicated to discovering and developing life-changing treatments for patients with neurological, psychiatric, and endocrine disorders. The company focuses on innovative therapies to address unmet medical needs in these therapeutic areas.

Source: https://www.neurocrine.com

valbenazineIngrezza

VMAT2 inhibitor

Ingrezza (valbenazine) is a vesicular monoamine transporter 2 (VMAT2) inhibitor from Neurocrine Biosciences. It is used in adults to treat tardive dyskinesia and the chorea associated with Huntington's disease, conditions marked by involuntary movements.

Valbenazine is a capsule taken once daily. It blocks VMAT2, a protein that loads dopamine into storage bubbles inside nerve cells. With less dopamine

1 medicine explained